Stockreport

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success [Yahoo! Finance]

Intra-Cellular Therapies Inc.  (ITCI) 
Last intra-cellular therapies inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intracellulartherapies.com/investor-relations
PDF Among these, biotech giant Regeneron REGN was in the news on a complaint alleging fraudulent drug pricing practices related to its lead drug, Eylea. Sage Therapeutics SA [Read more]